Slate Path Capital LP - Q2 2023 holdings

$2.73 Billion is the total value of Slate Path Capital LP's 49 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
TDG  TRANSDIGM GROUP INC$114,364,343
+21.3%
127,9000.0%4.18%
-5.5%
GDXJ  VANECK ETF TRUSTjunior gold mine$109,297,900
-9.7%
3,065,0000.0%4.00%
-29.7%
 CIVITAS RESOURCES INC$91,082,810
+1.5%
1,313,0000.0%3.33%
-21.0%
NOV  NOV INC$75,227,600
-13.3%
4,690,0000.0%2.75%
-32.5%
PAAS  PAN AMERN SILVER CORP$56,687,040
-19.9%
3,888,0000.0%2.07%
-37.6%
FERG  FERGUSON PLC NEW$47,664,930
+17.6%
303,0000.0%1.74%
-8.4%
 NOBLE CORP PLC$43,953,840
+4.7%
1,064,0000.0%1.61%
-18.5%
COIN  COINBASE GLOBAL INC$40,711,950
+5.9%
569,0000.0%1.49%
-17.6%
ITUB  ITAU UNIBANCO HLDG S Aspon adr rep pfd$18,549,600
+21.1%
3,144,0000.0%0.68%
-5.7%
BBD  BANCO BRADESCO S Asp adr pfd new$18,216,900
+32.1%
5,265,0000.0%0.67%
+2.8%
PTON  PELOTON INTERACTIVE INC$15,226,200
-32.2%
1,980,0000.0%0.56%
-47.2%
CUE  CUE BIOPHARMA INC$8,768,961
+2.2%
2,402,4550.0%0.32%
-20.3%
 INVIVYD INC$3,921,750
-12.5%
3,735,0000.0%0.14%
-31.9%
 RIVIAN AUTOMOTIVE INC$2,682,260
+7.6%
161,0000.0%0.10%
-16.2%
PLG  PLATINUM GROUP METALS LTD$1,278,000
-0.7%
900,0000.0%0.05%
-21.7%
NEXI  NEXIMMUNE INC$260,665
-25.8%
925,0000.0%0.01%
-41.2%
 AURORA INNOVATION INC*w exp 11/03/202$218,750
+143.7%
437,5000.0%0.01%
+100.0%
 BENSON HILL INC*w exp 09/29/202$49,500
+127.3%
250,0000.0%0.00%
+100.0%
 HIPPO HLDGS INC*w exp 08/02/202$13,195
-32.4%
350,0000.0%0.00%
-100.0%
BLUAWS  BLUERIVER ACQUISITION CORP*w exp 01/04/202$6,760
-57.8%
200,0000.0%0.00%
-100.0%
 BIRD GLOBAL INC*w exp 99/99/999$2,454
-31.8%
120,0000.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings